title: The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research.
abstract: Increasing numbers of human immunodeficiency virus (HIV)-infected women are now accessing life-prolonging highly active antiretroviral therapy (HAART) in developing countries. There is a need for better understanding of interactions of human papillomavirus (HPV) and HIV, especially in the context of increasing life expectancy due to HAART. The data regarding the impact of HAART on reducing the incidence and progression and facilitating the regression of HPV infection and cervical abnormalities is largely inconsistent. Published studies differ in their study designs (prospective or retrospective cohorts or record linkage studies), screening and diagnostic protocols, duration and type of HAART use, recruitment and referral strategies, and definitions of screening test and disease positivity. Due to the ethical and resource limitations in conducting randomized trials of the impact of HAART on incidence of HPV, CIN, and cervical cancer among HIV-infected women, it is important to consider innovative study designs, including quasi-experimental trials and operations research in sentinel populations to answer the critical research questions in this area.
authors.affiliation: Institute for Global Health and Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, USA. vikrant.sahasrabuddhe@vanderbilt.edu.
authors.forename: Lara F
authors.initials: LF
authors.lastname: Bratcher
authors.forename: Vikrant V
authors.initials: VV
authors.lastname: Sahasrabuddhe
references.citation: Ann Trop Med Parasitol. 2006 Jul-Sep;100(5-6):481-99
references.pmid: 16899150
references.citation: J Antimicrob Chemother. 2008 Jan;61(1):191-4
references.pmid: 17977910
references.citation: Br J Cancer. 2009 Mar 10;100(5):840-7
references.pmid: 19223894
references.citation: J Natl Cancer Inst. 2007 Jun 20;99(12):962-72
references.pmid: 17565153
references.citation: J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):274-82
references.pmid: 19387354
references.citation: Ann Intern Med. 2000 May 16;132(10):810-9
references.pmid: 10819705
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: J Infect Dis. 2003 Aug 15;188(4):555-63
references.pmid: 12898443
references.citation: J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):412-8
references.pmid: 16010162
references.citation: J Natl Cancer Inst. 2005 Apr 20;97(8):577-86
references.pmid: 15840880
references.citation: Gynecol Oncol. 2008 Sep;110(3):402-7
references.pmid: 18556050
references.citation: N Engl J Med. 2009 Jul 16;361(3):305; author reply 306
references.pmid: 19610158
references.citation: AIDS. 2009 Mar 27;23(6):N1-5
references.pmid: 19279439
references.citation: AIDS. 2002 Apr 12;16(6):927-9
references.pmid: 11919496
references.citation: Antivir Ther. 2006;11(8):1091-6
references.pmid: 17302379
references.citation: AIDS. 2001 Nov 9;15(16):2157-64
references.pmid: 11684935
references.citation: AIDS. 2006 Aug 1;20(12):1645-54
references.pmid: 16868446
references.citation: BMC Cancer. 2008 Jul 25;8:211
references.pmid: 18657270
references.citation: J Natl Cancer Inst Monogr. 2003;(31):41-6
references.pmid: 12807944
references.citation: J Infect Dis. 2003 Jul 1;188(1):128-36
references.pmid: 12825181
references.citation: AIDS. 1998 Aug 20;12(12):1459-64
references.pmid: 9727566
references.citation: Intervirology. 1993;36(2):57-64
references.pmid: 8294182
references.citation: Br J Dermatol. 2010 Jan;162(1):6-11
references.pmid: 19709102
references.citation: Obstet Gynecol. 2009 Jan;113(1):26-31
references.pmid: 19104356
references.citation: Int J Cancer. 2000 Jan 15;85(2):206-10
references.pmid: 10629079
references.citation: Anticancer Res. 2007 Jul-Aug;27(4A):1795-8
references.pmid: 17649775
references.citation: JAMA. 2000 Feb 23;283(8):1031-7
references.pmid: 10697063
references.citation: Vaccine. 2009 Jan 14;27(3):337-47
references.pmid: 19007840
references.citation: AIDS Res Hum Retroviruses. 2007 Aug;23(8):965-71
references.pmid: 17725412
references.citation: Top HIV Med. 2007 Aug-Sep;15(4):130-3
references.pmid: 17720998
references.citation: J Clin Pathol. 2008 Jan;61(1):84-8
references.pmid: 17483251
references.citation: Acta Biomed. 2007;78(1):36-40
references.pmid: 17687815
references.citation: AIDS. 1996 Jun;10(7):759-64
references.pmid: 8805867
references.citation: Cancer. 2009 Feb 1;115(3):524-30
references.pmid: 19127538
references.citation: J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):377-80
references.pmid: 11317082
references.citation: J Infect Dis. 2001 Sep 1;184(5):547-51
references.pmid: 11494160
references.citation: Gynecol Oncol. 1993 Feb;48(2):210-3
references.pmid: 8381376
references.citation: Infect Dis Clin North Am. 2007 Mar;21(1):1-17, vii
references.pmid: 17502227
references.citation: AIDS. 2002 Sep 6;16(13):1799-802
references.pmid: 12218392
references.citation: Nat Rev Cancer. 2004 Nov;4(11):861-75
references.pmid: 15516959
references.citation: Am J Prev Med. 2007 Aug;33(2):134-6
references.pmid: 17673101
references.citation: J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30
references.pmid: 11078759
references.citation: Int J Cancer. 2008 Jul 1;123(1):187-94
references.pmid: 18435450
references.citation: J Natl Cancer Inst. 2004 Jul 21;96(14):1070-6
references.pmid: 15265968
references.citation: J Pathol. 1999 Sep;189(1):12-9
references.pmid: 10451482
references.citation: Am J Obstet Gynecol. 2001 Mar;184(4):538-43
references.pmid: 11262450
references.citation: J Natl Cancer Inst. 2005 Mar 16;97(6):425-32
references.pmid: 15770006
references.citation: Virus Res. 1993 Feb;27(2):133-45
references.pmid: 8384765
references.citation: Clin Infect Dis. 2007 Aug 15;45(4):510-3
references.pmid: 17638204
references.citation: Clin Infect Dis. 2004 Mar 1;38(5):737-42
references.pmid: 14986260